Key Points
-
Sold all 3,185,000 shares of Immunome, estimated at $37.30 million based on quarterly average pricing
-
Quarter-end position value decreased by $37.30 million, reflecting both stock price movement and the sale
-
Represents a 4.92% decrease in Opaleye Management’s 13F reportable assets under management
-
Post-trade, Opaleye Management holds zero shares and zero dollar value in Immunome
-
The position accounted for 5.3% of fund AUM in the prior quarter, marking a significant shift in portfolio composition
- 10 stocks we like better than Immunome ›
On February 17, 2026, Opaleye Management Inc. reported selling out its entire stake in Immunome (NASDAQ:IMNM), an estimated $37.30 million trade based on quarterly average pricing.
What Happened
According to its SEC filing dated February 17, 2026, Opaleye Management Inc. sold all 3,185,000 shares of Immunome during the…
